AgTechLogic – Using Sensor Technology, AI and Data with Precision Spraying to Reduce Chemical Use in Agriculture up to 90%
AgTechLogic
From a business standpoint, investors should be excited about what we are doing because the food supply needs help. We are bringing technologies on a monthly agreement that is very affordable to growers. We are showing direct returns from our growers, so our growers understand they are saving money. We have a profitable business model, so I think investors will look at this and say that they want to see a financial return and an environmental and sustainability return as part of their investment in a company like ours.Tom Gauthier, CEO/Founder, AgTechLogic
The WaveDyn Vision Analyzer from WaveFront Dynamics: a new tool for Optometrists and Ophthalmologists; measuring more ocular detail for optimal treatment
WaveFront Dynamics Inc.
“Absolutely! We are seeking funding. We’ve invested a lot of money and effort to develop a product and now are trying to get into the market. We need funding to find the right sales venues, to hire salespeople, improve our product delivery infrastructure and other commercialization activities. We could use some investors, partners, distributors, contact lens companies or other treatment connections.“ Daniel Neal PhD, Founder & CEO, WaveFront Dynamics Inc.
PTM Therapeutics – Taking a Novel Approach to Treating Inflammatory Bowel Disease and Colon Cancer Using Monoclonal Antibody Technology to Target PTMs Found on Proteins
PTM Therapeutics
“What I want to emphasize is supporting the whole ecosystem. We are an early-
The investment community should be looking at companies that have novel ideas, but taking thoughtful, reasonable steps to develop therapeutics and investing in them and taking that risk. We are excited about novelty, but I feel that that novel equals risk in so many of the VC’s heads, and they tend to be risk averse. This is my shout-
Portal Instruments
“We are always looking for investors to take us further. We have been very blessed in that we have been able to attract a very diverse group of investors. We also have strategic partners on the pharma and manufacturing sides. We have always been able to present the company as valuable to the partners. At this time, we are looking for more financing to take us further through scale-
Sarcomatrix Therapeutics, Corporation
“To align with the current funding environment our strategy is to raise a $5M seed round to advance our small molecule S-
I've structured a $5 million seed convertible note and have secured a soft commitment of $1 million from the Battle Born Fund in Nevada. My efforts are now focused on engaging with various venture capitalists to find a syndicate lead who can contribute the remaining $4 million for this round.” David Craig, MBA, President and CEO, Sarcomatrix Therapeutics, Corporation
Safe-
“I never turn down money. Anybody that says they are not, is not being truthful. We are always interested. At this point, it would have to be a partnership with money. We are looking for a key investor at this point who has access to these people or industry access.” Bob Dudley, CEO, Safe-
https://ceocfointerviews.com/monstermushroomcompany23.html
“Absolutely! We are actively seeking an angel investor at this time. We have talked to a few groups and nothing concrete yet. Private funding is really the only way to scale this business, as we have talked about the lack of government funding.” David Muelken, Owner & CEO, Monster Mushroom Company
Upward Path Institute – Helping Students Across the U.S. Prepare for College Admissions, Choosing a Major and Career Path
https://ceocfointerviews.com/upwardpathinstitute23.html
“At this point especially with the Upward Path launch and its potential, we are indeed looking for funding. We are also looking for partnerships that can accelerate how quickly our solutions can be developed and spread the word.” Vinnie Gupta, President and Co-
Fortuna Business Management Consulting -
https://www.ceocfointerviews.com/fortunabmc23.html
“We're proud to be one of the fastest-
WatchRx Smartwatch Solution to Improve Medication Adherence for Seniors and Reduce Stress for Caregivers with Virtual Care Coordination Platform to Seamlessly Connect Healthcare Stakeholders
https://ceocfointerviews.com/watchrx23.html
“Yes, I am currently seeking a Seed Round of financing and also partners. I have established a few partnerships like distributors and reseller agreements, but I would definitely like more partnerships, especially with companies that can staff nurses. We also offer nurses for monitoring patients.” Jayanthi Narasimhan, Founder & CEO, WatchRx, Inc.
Successfully Automating Profits in Self-
https://ceocfointerviews.com/10federal23.html
“As I have gained experience fund raising from these institutions, I have learned that 10 Federal is at the intersection of two large paradigm shifts in our industry that these big investors are interested in. First is the theme of technology replacing labor, which in our case our automated platform is replacing labor. We no longer have property managers at the site, and as a result we have a more efficient operating expense profile, and that benefit goes straight to the bottom line.
Secondly, there is this concept called prop tech which is how technology can be used to enhance performance of real estate. Everything we are doing through automation and our data science system that lets us evaluate which facilities we should buy and estimates to what degree we can improve the performance has proven to be a tremendous value-
We check two boxes off at the same time and either one or the other would be generally very appealing to the larger investment community. By aligning with those two themes and demonstrating a proven track record through the successful sale of our first and second offerings we are achieving success in the capital raising world.” Brad Minsley, Principal & Co-
Croptix’s Innovative Technology for Sensing Nutrition and Disease in the Field Enables Farmers to Detect and Monitor Plant Health
https://www.ceocfointerviews.com/croptix23.html
“This recent funding is the initial closing of our first equity round, which is a Series Seed investment. We took time to identify a strategic investor as part of this round. We were looking for a partner that could help us accelerate the development of our nutritional assessment and open that market more quickly than it would have taken us to do it on our own. We have partnered with Advancing Eco Agriculture (AEA), and they are highly aligned with our vision. AEA is a leader in regenerative agriculture. With our joint solution, AEA’s customers will benefit by getting nutritional results much faster than with traditional methods. By having data faster, adjustments can be made sooner to optimize crop health. For example, you might need less fertilizer if you see the nutritional needs earlier. This is both a cost-
Working with AEA will be a game changer for us in terms of building out our nutritional platform more quickly, and we are excited about how that is coming together. We are looking forward to trial testing this summer and leveraging the resources between both teams for a successful launch of products for nutritional assessment in the field.
Participation in this round from early investors 1855 Capital and Ben Franklin Technology Partners demonstrates their strong confidence in our future success. We are grateful for their ongoing commitment and support.” Perry Edwards, Ph.D., Co-
Investor Opportunity | Investing Opportunities | Angel Investor Opportunities | Seed Round Funding | Seed Round Fundraising | Seed Round Financing Opportunities | Private Funding | Private Equity Funding Opportunities | Private Equity Investor Opportunity | Minority Stakes Funding | Companies Raising Funds | Companies Raising Capital | Large Investment Opportunities | Companies in First Equity Round | Series Seed Investment Opportunities | Partnership Opportunities | Distributor Opportunities | CEOs looking for Funding | CEO Interviews | CEOCFO Interviews | CEOCFO Magazine Interviews | CEOCFO Investor Opportunity | CEOCFO Investing Opportunities
Battle Financial, Inc.
